What medications are used to treat menopause symptoms?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medications for Menopause Symptoms

For menopausal symptoms, first-line treatment should include nonhormonal options such as SNRIs, SSRIs, gabapentin, and lifestyle modifications, with hormonal therapy reserved for those without contraindications who have persistent symptoms. 1

Vasomotor Symptoms (Hot Flashes/Night Sweats)

Nonhormonal Pharmacologic Options (First-Line)

  • SNRIs/SSRIs:

    • Venlafaxine (SNRI): Safe and effective for reducing hot flashes 1
    • Paroxetine (SSRI): Use with caution in women taking tamoxifen due to CYP2D6 inhibition 1
    • Typically require lower doses than those used for depression 1
  • Anticonvulsants:

    • Gabapentin: Effective for reducing hot flash frequency and severity 1
    • Pregabalin: Alternative option with similar efficacy 1
  • Other medications:

    • Clonidine (antihypertensive): Used clinically for hot flashes 1

Hormonal Options (Second-Line)

  • Estrogen therapy: Most effective treatment for vasomotor symptoms 2, 3
    • For women with intact uterus: Must combine with progestin to prevent endometrial cancer 1, 2
    • For women without uterus: Estrogen alone 1
    • Contraindicated in women with history of hormone-dependent cancers 1
    • Formulations include oral tablets, transdermal patches, gels, and sprays 2

Vaginal/Urogenital Symptoms

Nonhormonal Options (First-Line)

  • Vaginal moisturizers and lubricants:

    • Water-based or silicone-based products 1
    • Silicone-based products may last longer than water-based products 1
    • Can be used in combination for additional comfort 1
  • Ospemifene: FDA-approved nonhormonal treatment for dyspareunia due to menopausal atrophy 4

Hormonal Options (Second-Line)

  • Local estrogen therapy:
    • Vaginal tablets, creams, or rings 1
    • Takes 6-12 weeks for full effect 1
    • May be used cautiously in women with breast cancer history, though safety not well established 1
    • Not recommended for women on aromatase inhibitors 1

Special Considerations

Breast Cancer Survivors

  • Avoid systemic hormone therapy 1, 5
  • Preferred options:
    • SNRIs (venlafaxine preferred) 1
    • SSRIs (avoid paroxetine with tamoxifen) 1
    • Gabapentin 1
    • Nonhormonal vaginal moisturizers for vaginal symptoms 1

Complementary Approaches

  • Lifestyle modifications:

    • Environmental modifications (cool rooms, dressing in layers) 1
    • Avoiding triggers (spicy foods, caffeine, alcohol) 1
    • Regular exercise 1
    • Rhythmic breathing techniques 1
  • Other therapies with some evidence:

    • Acupuncture: Shown to reduce menopausal symptoms in meta-analysis 1
    • Soy products: Modest improvement in hot flashes and vaginal dryness 4
    • Clinical hypnosis: May significantly reduce hot flashes 4

Treatment Algorithm

  1. Assess symptom severity and impact on quality of life
  2. Rule out other medical causes (thyroid disease, diabetes) 1
  3. For vasomotor symptoms:
    • Start with nonhormonal options (SNRIs/SSRIs, gabapentin) and lifestyle modifications
    • If inadequate relief and no contraindications, consider hormone therapy
  4. For vaginal symptoms:
    • Start with nonhormonal moisturizers and lubricants
    • If inadequate relief, consider local vaginal estrogen (if no contraindications)

Common Pitfalls to Avoid

  • Using systemic hormone therapy in women with history of breast cancer 1, 5
  • Prescribing estrogen alone in women with intact uterus (increases endometrial cancer risk) 1
  • Using paroxetine in women taking tamoxifen (may reduce tamoxifen efficacy) 1
  • Continuing hormone therapy longer than necessary (increased breast cancer risk with combined therapy used >3-5 years) 4
  • Overlooking nonpharmacological approaches that may provide significant relief 1

Remember that menopausal symptoms can persist for more than a decade, with genitourinary symptoms typically being progressive 6. Timely and appropriate treatment can significantly improve quality of life during this transition.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Management of perimenopausal and menopausal symptoms.

BMJ (Clinical research ed.), 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.